Medeon Biodesign, Inc. (TPEX:6499)

Medeon Biodesign Revenue

Medeon Biodesign had revenue of 106.61M TWD in the quarter ending June 30, 2026, a decrease of -3.42%. This brings the company's total for the last twelve months to 428.07M, up 8.54% year-over-year. In the year 2025, Medeon Biodesign had annual revenue of 419.43M with 43.24% growth. That makes Medeon Biodesign the 36,051st largest company in the world by revenue and 1,874th in Taiwan.

• Revenue (ttm): 428.07M
• Revenue Growth: +8.54%
• P/S Ratio: 16.76
• Revenue / Employee: 10.98M
• Employees: 39
• Market Cap: 7.17B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Medical Parts Sales Department 253.47M 86.6%
• Development Department 39.34M 13.4%

Fiscal year ended Dec 31, 2024 See the full Medeon Biodesign breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	419.43M	126.62M	43.24%
Dec 31, 2024	292.81M	96.55M	49.19%
Dec 31, 2023	196.26M	-102.05M	-34.21%
Dec 31, 2022	298.32M	229.36M	332.61%
Dec 31, 2021	68.96M	-54.10M	-43.96%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error